Literature DB >> 12007178

Biomimetic studies on iodothyronine deiodinase intermediates: modeling the reduction of selenenyl iodide by thiols.

Govindasamy Mugesh1, Wolf-Walther du Mont, Cathleen Wismach, Peter G Jones.   

Abstract

Enzyme mimetic studies on the crucial intermediate (E-SeI) of the iodothyronine deiodinase cycle have been carried out by using an areneselenenyl iodide stabilized by intramolecular Se.N interactions. Treatment of this compound with aromatic thiols and thiobenzoxazole in the presence of NEt(3) affords areneselenenyl sulfides that are stable towards disproportionation reactions. The structures of three of the areneselenenyl sulfides were determined by X-ray crystallography. In one case, in the absence of NEt(3), a diselenide can be formed rather than the selenenyl sulfide. The areneselenenyl iodide also reacts with a related selenol to produce the corresponding diselenide, and this reaction is found to be much faster than that with thiols. The high reactivity of the selenenyl iodide with the selenol suggests that a reduced selenol group (R'-SeH) may react with the E-SeI intermediate to produce a diselenide (E-Se-Se-R') without any thiol cosubstrate. The intermediacy of selenenyl sulfides during the reduction of selenenyl iodide by thiols and its possible relevance to the iodothyronine deiodinase catalytic cycle is also described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007178     DOI: 10.1002/1439-7633(20020503)3:5<440::AID-CBIC440>3.0.CO;2-8

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  2 in total

1.  Synthetic seleno-glutaredoxin 3 analogues are highly reducing oxidoreductases with enhanced catalytic efficiency.

Authors:  Norman Metanis; Ehud Keinan; Philip E Dawson
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

2.  Chemistry and Chemical Biology of Selenenyl Sulfides and Thioseleninic Acids.

Authors:  Akil Hamsath; Ming Xian
Journal:  Antioxid Redox Signal       Date:  2020-04-16       Impact factor: 8.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.